Agilent | A - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
Agilent USD 399M 46M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 10.2M 66.1M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Henry Schein USD 182M 4M 2026-03
Illumina USD 239M 17M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -31.8M 5.5M 2026-03
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 148M 122.52M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03